Formula for treating coronary heart disease
A technology of coronary heart disease and formula, which is applied in the field of formula for the treatment of coronary heart disease, can solve the problems of uneven quality, great difference in curative effect, and inability to discharge from skin pores, etc., to achieve rapid onset, scientific compatibility, and good curative effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0007] A formula for treating coronary heart disease. The raw materials in the formula are composed by weight percentage: catkin 5%, Wangyou 1%, notopterygium 1%, agarwood 5%, donkey-hide gelatin 3%, coix seed 2%, coptis 1%, French Summer 11%, honeysuckle 5%, chondroitin sulfate 3%, nifedipine 3%, simvastatin 1%, rhodiola 5%, sky blue 1%, balsamic 4%, medlar 2%, seabuckthorn 0.4% , 1% of old tea tree roots, and 2% of Millet Spatholobus. At this time, the thermal shock resistance for the treatment of coronary heart disease is excellent, but the high temperature resistance is insufficient.
Embodiment 2
[0009] A formula for treating coronary heart disease. The raw materials in the formula are composed of 15% Chinese catkin, 5% Wangyou, 10% notopterygium, 15% agarwood, 9% donkey-hide gelatin, 3% coix seed, 5% coptis, and Summer 19%, honeysuckle 7%, chondroitin sulfate 5%, nifedipine 5%, simvastatin 5%, rhodiola rosea 10%, sky blue 1.5%, balsamic 5%, medlar 4%, seabuckthorn 0.6% , 2% of old tea tree roots, and 4% of Mildew Spatholobus. At this time, the treatment of coronary heart disease has high temperature resistance, but its thermal shock resistance is insufficient.
Embodiment 3
[0011] A formula for treating coronary heart disease. The raw materials in the formula are composed by weight percentage: 10% Chinese catkins, 3% Wangyou, 7% notopterygium, 11% agarwood, 7% donkey-hide gelatin, 2.3% coix seed, 4% rhizoma coptis, and Summer 18%, honeysuckle 5.7%, chondroitin sulfate 3.5%, nifedipine 3.5%, simvastatin 1.5%, rhodiola rosea 8%, sky blue 1%, balsamic 4.5%, medlar 2.4%, seabuckthorn 0.5% , 1.2% of old tea tree roots, and 2.4% of Millet Spatholobus, at this time, the treatment of coronary heart disease has high thermal shock stability and high temperature resistance.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com